29 Jan 2025
// PR NEWSWIRE
01 Jan 2025
// FDA
18 Dec 2024
// PR NEWSWIRE
Latest Content by PharmaCompass
Reset all filters
01 2ACETAZOLAMIDE
02 6AMITRIPTYLINE HYDROCHLORIDE
03 2APIXABAN
04 3ASENAPINE MALEATE
05 2BENDAMUSTINE HYDROCHLORIDE
06 1BRETYLIUM TOSYLATE
07 1CABAZITAXEL
08 2CARFILZOMIB
09 3DABIGATRAN ETEXILATE MESYLATE
10 4DULOXETINE HYDROCHLORIDE
11 2ENTECAVIR
12 2EPLERENONE
13 2ESTRADIOL; NORETHINDRONE ACETATE
14 7EVEROLIMUS
15 1EXEMESTANE
16 4FLUPHENAZINE HYDROCHLORIDE
17 1LAMIVUDINE
18 1METHADONE HYDROCHLORIDE
19 2METHSCOPOLAMINE BROMIDE
20 1METHYLERGONOVINE MALEATE
21 1MONTELUKAST SODIUM
22 1NOREPINEPHRINE BITARTRATE
23 3OMEPRAZOLE
24 3OXCARBAZEPINE
25 1PENICILLAMINE
26 2PIROXICAM
27 1POLYETHYLENE GLYCOL 3350
28 4POMALIDOMIDE
29 2POTASSIUM CHLORIDE
30 3RIVAROXABAN
31 3RIVASTIGMINE
32 2SOLIFENACIN SUCCINATE
33 1SUCCINYLCHOLINE CHLORIDE
34 1TERBINAFINE HYDROCHLORIDE
35 2TERIFLUNOMIDE
36 2TETRACYCLINE HYDROCHLORIDE
37 1TOFACITINIB
38 2TRIAZOLAM
39 3TRIMIPRAMINE MALEATE
40 1ZOLEDRONIC ACID
41 2ZOLPIDEM TARTRATE
Reset all filters
01 80BRECKENRIDGE
02 9BRECKENRIDGE PHARM
03 1BRECKENRIDGE PHARMS
Reset all filters
01 7CAPSULE, DELAYED REL PELLETS;ORAL
02 15CAPSULE;ORAL
03 3FILM, EXTENDED RELEASE;TRANSDERMAL
04 1FOR SOLUTION;ORAL
05 5INJECTABLE;INJECTION
06 1INJECTABLE;INTRAVENOUS
07 4POWDER;INTRAVENOUS
08 1SOLUTION;INTRAVENOUS
09 4TABLET, EXTENDED RELEASE;ORAL
10 46TABLET;ORAL
11 3TABLET;SUBLINGUAL
Reset all filters
01 10.125MG
02 20.25MG
03 10.2MG/ML
04 20.5MG
05 10.5MG;0.1MG
06 10.75MG
07 1100MG
08 1100MG/VIAL
09 110MEQ
10 710MG
11 110MG/ML
12 110MG/VIAL
13 112.5MG
14 1125MG
15 113.3MG/24HR
16 114MG
17 3150MG
18 115MG
19 117GM/SCOOPFUL
20 31MG
21 11MG;0.5MG
22 42.5MG
23 120MEQ
24 320MG
25 120MG/ML
26 3250MG
27 325MG
28 125MG/VIAL
29 12MG
30 1300MG
31 13MG
32 14.6MG/24HR
33 140MG
34 14MG
35 1500MG
36 250MG
37 150MG/ML
38 65MG
39 16.25MG
40 1600MG
41 160MG/1.5ML (40MG/ML)
42 160MG/VIAL
43 17.5MG
44 175MG
45 17MG
46 19.5MG/24HR
47 1EQ 100MG BASE
48 2EQ 10MG BASE
49 1EQ 110MG BASE
50 1EQ 150MG BASE
51 1EQ 1MG BASE/ML
52 1EQ 2.5MG BASE
53 1EQ 20MG BASE
54 1EQ 250MG BASE
55 1EQ 25MG BASE
56 1EQ 30MG BASE
57 1EQ 40MG BASE
58 1EQ 4MG BASE/5ML
59 1EQ 50MG BASE
60 1EQ 5MG BASE
61 1EQ 60MG BASE
62 1EQ 75MG BASE
Reset all filters
01 90USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ACETAZOLAMIDE
Dosage Strength : 125MG
Packaging :
Approval Date : 2020-04-30
Application Number : 207503
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : ACETAZOLAMIDE
Dosage Strength : 250MG
Packaging :
Approval Date : 2020-04-30
Application Number : 207503
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMITRIPTYLINE HYDROCHLORI...
Dosage Strength : 10MG
Packaging :
Approval Date : 2022-06-06
Application Number : 216243
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMITRIPTYLINE HYDROCHLORI...
Dosage Strength : 25MG
Packaging :
Approval Date : 2022-06-06
Application Number : 216243
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMITRIPTYLINE HYDROCHLORI...
Dosage Strength : 50MG
Packaging :
Approval Date : 2022-06-06
Application Number : 216243
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMITRIPTYLINE HYDROCHLORI...
Dosage Strength : 75MG
Packaging :
Approval Date : 2022-06-06
Application Number : 216243
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMITRIPTYLINE HYDROCHLORI...
Dosage Strength : 100MG
Packaging :
Approval Date : 2022-06-06
Application Number : 216243
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : AMITRIPTYLINE HYDROCHLORI...
Dosage Strength : 150MG
Packaging :
Approval Date : 2022-06-06
Application Number : 216243
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : APIXABAN
Dosage Strength : 2.5MG
Packaging :
Approval Date : 2021-07-26
Application Number : 209845
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Dosage Form : TABLET;ORAL
Brand Name : APIXABAN
Dosage Strength : 5MG
Packaging :
Approval Date : 2021-07-26
Application Number : 209845
Regulatory Info : DISCN
Registration Country : USA